Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions
How Private Equity Is Consolidating the Pharmacy Benefit Manager Industry
Episode 32 of The Buyout Show dives into one of the most opaque corners of American healthcare: pharmacy benefit managers, or PBMs. Lucas and Luna unpack the recent roll-up of mid-tier PBMs by private equity firms, focusing on the 2025 acquisition of EmpiRx Health by a consortium led by New Mountain Capital. They walk through how PBMs sit between insurers, drug manufacturers, and patients, and why PE sees massive margin potential in aggregating these middlemen. With the three largest PBMs (Caremark, Express Scripts, OptumRx) controlling nearly 80% of the market, the playbook has shifted to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.